What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
Sustained abstinence is currently the only accepted end-point for pharmacotherapy trials for most substance use disorders (SUD), with the exception of alcohol. Despite recent efforts, the identification of a non-abstinence alternative as a clinically meaningful end-point for drug use trials has been...
Guardat en:
| Autor principal: | |
|---|---|
| Altres autors: | |
| Format: | Journal Article |
| Idioma: | anglès |
| Matèries: | |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Ítems similars: What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
- Cigarette smoke directly impairs skeletal muscle function through capillary regression and altered myofiber calcium kinetics in mice
- Brief school-based interventions and behavioural outcomes for substance-using adolescents (Review)
- Public health consequences of e-cigarettes
- Costs and unintended consequences of drug control policies
- The effectiveness of self-directed medical cannabis treatment for pain
- Usages de drogues en prision. Pratiques, conséquences et réponses